Your browser doesn't support javascript.
loading
Determination of the CD148-Interacting Region in Thrombospondin-1.
Takahashi, Keiko; Sumarriva, Katherine; Kim, Rachel; Jiang, Rosie; Brantley-Sieders, Dana M; Chen, Jin; Mernaugh, Raymond L; Takahashi, Takamune.
Affiliation
  • Takahashi K; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Sumarriva K; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Kim R; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Jiang R; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Brantley-Sieders DM; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Chen J; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Mernaugh RL; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Takahashi T; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
PLoS One ; 11(5): e0154916, 2016.
Article in En | MEDLINE | ID: mdl-27149518
ABSTRACT
CD148 is a transmembrane protein tyrosine phosphatase that is expressed in multiple cell types, including vascular endothelial cells and duct epithelial cells. Previous studies have shown a prominent role of CD148 to reduce growth factor signals and suppress cell proliferation and transformation. Further, we have recently shown that thrombospondin-1 (TSP1) serves as a functionally important ligand for CD148. TSP1 has multiple structural elements and interacts with various cell surface receptors that exhibit differing effects. In order to create the CD148-specific TSP1 fragment, here we investigated the CD148-interacting region in TSP1 using a series of TSP1 fragments and biochemical and biological assays. Our results demonstrate that 1) CD148 binds to the 1st type 1 repeat in TSP1; 2) Trimeric TSP1 fragments that contain the 1st type repeat inhibit cell proliferation in A431D cells that stably express wild-type CD148 (A431D/CD148wt cells), while they show no effects in A431D cells that lack CD148 or express a catalytically inactive form of CD148. The anti-proliferative effect of the TSP1 fragment in A431D/CD148wt cells was largely abolished by CD148 knockdown and antagonized by the 1st, but not the 2nd and 3rd, type 1 repeat fragment. Furthermore, the trimeric TSP1 fragments containing the 1st type repeat increased the catalytic activity of CD148 and reduced phospho-tyrosine contents of EGFR and ERK1/2, defined CD148 substrates. These effects were not observed in the TSP1 fragments that lack the 1st type 1 repeat. Last, we demonstrate that the trimeric TSP1 fragment containing the 1st type 1 repeat inhibits endothelial cell proliferation in culture and angiogenesis in vivo. These effects were largely abolished by CD148 knockdown or deficiency. Collectively, these findings indicate that the 1st type 1 repeat interacts with CD148, reducing growth factor signals and inhibiting epithelial or endothelial cell proliferation and angiogenesis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombospondin 1 Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombospondin 1 Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: United States